Pac man eat MA deal buy sell merger
Biotech

Novo makes bombshell $6.5B counteroffer to Pfizer's obesity buy

Novo Nordisk has thrown a curveball at Pfizer by attempting to outbid the U.S. pharma for the obesity biotech Metsera.
James Waldron Oct 30, 2025 7:51am
GeminiGeneratedImagewmbtpzwmbtpzwmbtpng

First FDA IND Milestone Using Human Vascularized Organoid Data

Oct 27, 2025 8:00am
Red stop sign on road

Eli Lilly sidelines pain prospect in another pipeline shift

Oct 30, 2025 2:19pm
GettyImages-1494029118jpg

iRegene's Scalable Tech Unlocks Commercial Cell Therapies

Oct 27, 2025 8:00am
red and yellow background with scissors

BMS removes 2 clinical programs from pipeline

Oct 30, 2025 1:14pm
IPO art

Evommune prices IPO amid government shutdown

Oct 30, 2025 12:34pm
More News

Sensei drops sole clinical-stage cancer drug, plans layoffs

Oct 30, 2025 9:52am

Takeda drops AZ-partnered neurological program after ph. 2 fail

Oct 30, 2025 9:25am

FDA puts Intellia CRISPR trials on hold over raised liver enzyme

Oct 30, 2025 6:37am

Boehringer returns to Kyowa with €640M pact for autoimmune drug

Oct 30, 2025 6:03am